Rebound insomnia: its determinants and significance

Area of Science:

• Sleep Medicine
• Pharmacology

Background:

• Rebound insomnia is a sleep disturbance following benzodiazepine discontinuation.
• It manifests as increased wakefulness exceeding baseline levels.
• Observed in both patients and healthy subjects.

Purpose of the Study:

• To review determinants, mechanisms, and clinical significance of rebound insomnia.
• To consolidate current knowledge on this sleep disturbance.

Main Methods:

• Literature review of available information on rebound insomnia.
• Analysis of factors influencing its occurrence and characteristics.

Main Results:

• Rebound insomnia typically lasts one to two nights.
• Primarily associated with short- to intermediate-acting benzodiazepines.
• Occurs at high drug doses, beyond peak hypnotic effect.

Conclusions:

• Individual differences in experiencing rebound insomnia exist but are not well-defined.
• Avoidance strategies include low-dose initiation and gradual dose tapering.
• Understanding these factors aids in managing benzodiazepine withdrawal.